164 related articles for article (PubMed ID: 21386950)
1. Duloxetine in the treatment of chronic pain due to fibromyalgia and diabetic neuropathy.
Wright A; Luedtke KE; Vandenberg C
J Pain Res; 2010 Dec; 4():1-10. PubMed ID: 21386950
[TBL] [Abstract][Full Text] [Related]
2. Duloxetine in the treatment of generalized anxiety disorder.
Wright A; Vandenberg C
Int J Gen Med; 2009 Dec; 2():153-62. PubMed ID: 20360899
[TBL] [Abstract][Full Text] [Related]
3. Efficacy and safety of duloxetine in patients with chronic low back pain.
Skljarevski V; Desaiah D; Liu-Seifert H; Zhang Q; Chappell AS; Detke MJ; Iyengar S; Atkinson JH; Backonja M
Spine (Phila Pa 1976); 2010 Jun; 35(13):E578-85. PubMed ID: 20461028
[TBL] [Abstract][Full Text] [Related]
4. Randomized, Double-blind, Placebo-controlled Phase III Trial of Duloxetine Monotherapy in Japanese Patients With Chronic Low Back Pain.
Konno S; Oda N; Ochiai T; Alev L
Spine (Phila Pa 1976); 2016 Nov; 41(22):1709-1717. PubMed ID: 27831985
[TBL] [Abstract][Full Text] [Related]
5. Efficacy and safety of duloxetine versus placebo in adolescents with juvenile fibromyalgia: results from a randomized controlled trial.
Upadhyaya HP; Arnold LM; Alaka K; Qiao M; Williams D; Mehta R
Pediatr Rheumatol Online J; 2019 May; 17(1):27. PubMed ID: 31138224
[TBL] [Abstract][Full Text] [Related]
6. A double-blind, multicenter trial comparing duloxetine with placebo in the treatment of fibromyalgia patients with or without major depressive disorder.
Arnold LM; Lu Y; Crofford LJ; Wohlreich M; Detke MJ; Iyengar S; Goldstein DJ
Arthritis Rheum; 2004 Sep; 50(9):2974-84. PubMed ID: 15457467
[TBL] [Abstract][Full Text] [Related]
7. Duloxetine for treating painful neuropathy or chronic pain.
Lunn MP; Hughes RA; Wiffen PJ
Cochrane Database Syst Rev; 2009 Oct; (4):CD007115. PubMed ID: 19821395
[TBL] [Abstract][Full Text] [Related]
8. Duloxetine: a review of its use in the treatment of generalized anxiety disorder.
Carter NJ; McCormack PL
CNS Drugs; 2009; 23(6):523-41. PubMed ID: 19480470
[TBL] [Abstract][Full Text] [Related]
9. Duloxetine for painful diabetic neuropathy and fibromyalgia pain: systematic review of randomised trials.
Sultan A; Gaskell H; Derry S; Moore RA
BMC Neurol; 2008 Aug; 8():29. PubMed ID: 18673529
[TBL] [Abstract][Full Text] [Related]
10. Serotonin and Norepinephrine Reuptake Inhibitors.
Shelton RC
Handb Exp Pharmacol; 2019; 250():145-180. PubMed ID: 30838456
[TBL] [Abstract][Full Text] [Related]
11. Duloxetine 60 mg once-daily in the treatment of painful physical symptoms in patients with major depressive disorder.
Brannan SK; Mallinckrodt CH; Brown EB; Wohlreich MM; Watkin JG; Schatzberg AF
J Psychiatr Res; 2005 Jan; 39(1):43-53. PubMed ID: 15504423
[TBL] [Abstract][Full Text] [Related]
12. Duloxetine in the management of diabetic peripheral neuropathic pain.
Ormseth MJ; Scholz BA; Boomershine CS
Patient Prefer Adherence; 2011; 5():343-56. PubMed ID: 21845034
[TBL] [Abstract][Full Text] [Related]
13. A review of duloxetine 60 mg once-daily dosing for the management of diabetic peripheral neuropathic pain, fibromyalgia, and chronic musculoskeletal pain due to chronic osteoarthritis pain and low back pain.
Pergolizzi JV; Raffa RB; Taylor R; Rodriguez G; Nalamachu S; Langley P
Pain Pract; 2013 Mar; 13(3):239-52. PubMed ID: 22716295
[TBL] [Abstract][Full Text] [Related]
14. A randomized, double-blind, placebo-controlled trial of duloxetine in the treatment of women with fibromyalgia with or without major depressive disorder.
Arnold LM; Rosen A; Pritchett YL; D'Souza DN; Goldstein DJ; Iyengar S; Wernicke JF
Pain; 2005 Dec; 119(1-3):5-15. PubMed ID: 16298061
[TBL] [Abstract][Full Text] [Related]
15. Duloxetine, 60 mg once daily, for major depressive disorder: a randomized double-blind placebo-controlled trial.
Detke MJ; Lu Y; Goldstein DJ; Hayes JR; Demitrack MA
J Clin Psychiatry; 2002 Apr; 63(4):308-15. PubMed ID: 12000204
[TBL] [Abstract][Full Text] [Related]
16. Efficacy and safety of duloxetine 30 mg/d in patients with fibromyalgia: a randomized, double-blind, placebo-controlled study.
Arnold LM; Zhang S; Pangallo BA
Clin J Pain; 2012; 28(9):775-81. PubMed ID: 22971669
[TBL] [Abstract][Full Text] [Related]
17. Profile of adverse events with duloxetine treatment: a pooled analysis of placebo-controlled studies.
Brunton S; Wang F; Edwards SB; Crucitti AS; Ossanna MJ; Walker DJ; Robinson MJ
Drug Saf; 2010 May; 33(5):393-407. PubMed ID: 20397739
[TBL] [Abstract][Full Text] [Related]
18. Comparisons of the efficacy and safety of duloxetine for the treatment of fibromyalgia in patients with versus without major depressive disorder.
Arnold LM; Hudson JI; Wang F; Wohlreich MM; Prakash A; Kajdasz DK; Chappell AS
Clin J Pain; 2009; 25(6):461-8. PubMed ID: 19542792
[TBL] [Abstract][Full Text] [Related]
19. Long-term safety, tolerability, and efficacy of duloxetine in the treatment of fibromyalgia.
Mease PJ; Russell IJ; Kajdasz DK; Wiltse CG; Detke MJ; Wohlreich MM; Walker DJ; Chappell AS
Semin Arthritis Rheum; 2010 Jun; 39(6):454-64. PubMed ID: 19152958
[TBL] [Abstract][Full Text] [Related]
20. Duloxetine for the treatment of fibromyalgia in women: pooled results from two randomized, placebo-controlled clinical trials.
Arnold LM; Pritchett YL; D'Souza DN; Kajdasz DK; Iyengar S; Wernicke JF
J Womens Health (Larchmt); 2007 Oct; 16(8):1145-56. PubMed ID: 17937567
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
